Aptamedica
Startup · Warsaw, Poland
Aptamedica is a Warsaw-based medtech startup developing a real-time, point-of-care therapeutic drug monitoring platform for intensive and critical care. Its core product, AptaSense, is a bedside analyzer that uses single-use, aptamer-based (DNA biosensor) test strips to measure blood concentrations of antibiotics such as vancomycin, gentamicin and amikacin, plus the sepsis biomarker procalcitonin, returning results in roughly one minute from a venous sample — removing the need to send samples to a central lab and enabling immediate, precise dosing. The platform extends beyond the handheld analyzer: AptaFlow integrates into haemodialysis circuits for continuous real-time drug monitoring, while AptaSoft is an AI-assisted dosing tool aimed at neonatal care. New analytes such as troponin and digoxin are in the development pipeline and can be added via software. Founded by Maciej Łach, Mateusz Fil and Kamil Pawełkiewicz, the company is at prototype stage and has taken part in Polish innovation programmes including Warsaw Booster and the Mother and Child Startup Challenge; no external funding round has been publicly disclosed to date.
Connection map
Drag nodes to rearrange · scroll or pinch to zoom · click a node to open it